Australia has never recorded a locally transmitted case of Ebola virus disease. That fact, while reassuring, is not a reason to be unprepared. In a world where international travel connects Australian workers to every corner of the globe, the possibility of a returning traveller presenting with Ebola virus disease (EVD) is something every healthcare facility, employer, and workplace safety professional needs to plan for — not panic over, but genuinely prepare for.
The good news is that Ebola is not easy to transmit. It is not airborne in the way influenza or COVID-19 spreads. It requires direct contact with infected bodily fluids from a symptomatic person. That means the right workplace protocols, properly trained staff, and solid infection control systems are genuinely effective at preventing transmission. This guide breaks down what Australian workplaces need to know in 2026.
What Is Ebola Virus Disease and Why Does It Matter to Australian Workplaces?
Ebola virus disease is a severe illness caused by one of several species of Ebola virus — with the Zaire species historically carrying the highest fatality rate, estimated between 50% and 90% depending on the outbreak and access to medical care. It belongs to a group of conditions called viral haemorrhagic fevers (VHFs), alongside Marburg disease and Lassa fever.
The Australian Centre for Disease Control notes that while Ebola remains rare globally, outbreaks can grow quickly and carry very high fatality rates — and people can become infected if they travel to areas where the disease is present.
Under Australian law, EVD is a Listed Human Disease under the Biosecurity Act 2015 and is also listed as a notifiable disease under the National Health Security Act 2007. This means any suspected or confirmed case triggers immediate, mandatory reporting obligations — not optional ones.
For most Australian workplaces, the primary risk scenario is a returning traveller — a nurse who volunteered in an outbreak region, a mining contractor who worked in Central or West Africa — presenting with symptoms. The infection control response in those early hours determines everything that comes next.
How Ebola Spreads — and How It Doesn't
Understanding the actual transmission routes of EVD is essential before designing any workplace response.
The virus spreads through close contact with the blood, secretions, organs, or other bodily fluids of infected people — both living and deceased — and through indirect contact with environments contaminated with those fluids. In healthcare settings specifically, transmission can occur where infection control compliance is incomplete — including through reuse of sharps, use of improperly sterilised equipment, or lapses in appropriate PPE use.
What Ebola does not do is spread through casual or remote contact. Ebola is not transmitted through aerosols, though caution is warranted when aerosol-generating procedures are undertaken in clinical settings. You cannot contract it by being in the same room as someone who is infected — not without direct fluid exposure.
The incubation period ranges from 2 to 21 days, with 8 to 10 days being most common. People are infectious for as long as their blood and secretions contain the virus. This incubation window is precisely why the 21-day monitoring period matters in contact tracing.
Australia's Regulatory Framework for EVD Response
Australian workplaces don't operate in a vacuum when it comes to infectious disease management. Several layers of legislation and guidance apply.
The Communicable Diseases Network Australia (CDNA) publishes the national guidelines for public health units responding to EVD, endorsed by the Australian Health Protection Principal Committee (AHPPC). These guidelines set the nationally consistent minimum standard for infection control, case management, and contact tracing.
State health authorities publish their own guidance aligned with the national framework. Queensland Health advises clinicians to remain alert to the possibility of viral haemorrhagic fevers in unwell travellers returning from affected areas and references the WHO and Travel Health Pro Outbreak Surveillance page for current outbreak status.
At the workplace level, the Work Health and Safety Act 2011 places a general duty on employers to ensure the health and safety of their workers. In practice, this means having documented procedures for managing biological hazards — including emerging infectious disease risks like EVD.
An infection prevention and control (IPC) program should form part of a broader risk management system designed to identify, assess, mitigate, and communicate potential communicable disease threats to both patients and staff.
The Role of Personal Protective Equipment (PPE)
PPE is the most visible element of EVD infection control, but it is far from the only one — and wearing it incorrectly can actually increase risk rather than reduce it.
PPE alone is not sufficient to prevent the spread of infection. Its use must go hand-in-hand with other infection control measures, including screening and isolating patients who may have Ebola, handwashing, injection safety, and environmental cleaning and waste management.
The selection of PPE must be based on a risk assessment that considers the type of planned interventions, the patient's degree of infectivity, and the workplace environment. Workplace health and safety experts and infection prevention and control professionals with expertise in PPE should oversee the selection process.
In Australian healthcare settings, the approach is tiered. Patients with suspected or confirmed Ebola are managed in designated quarantine hospitals — in South Australia, for example, that means the Royal Adelaide Hospital or the Women's and Children's Hospital — with enhanced precautions and additional PPE following local protocols. This includes placing the patient in a single room with an en-suite bathroom.
In Australia, people under investigation for possible EVD infection are likely to present with mild, non-secretory symptoms initially. The risk assessment must be reviewed frequently as the disease progresses, because the level of PPE required changes as the patient's condition evolves.
One practical area of debate in Australia has been the use of alcohol-based hand rubs on gloved hands. Hand Hygiene Australia has noted that while use of alcohol-based hand rubs on nitrile gloves is unlikely to cause harm and may reduce the risk of self-contamination, it is not a substitute for appropriate PPE when caring for a patient with suspected or confirmed EVD.
Infection Control Principles for Australian Workplaces
Screening and Early Identification
The earlier a potential EVD case is identified, the more effectively transmission can be prevented. For healthcare facilities, this means asking every unwell patient about recent travel history — particularly to Sub-Saharan Africa — as part of routine triage.
A nurse working in a Sydney emergency department once described how a simple travel question at triage changed the management of a patient who had returned from the Democratic Republic of Congo with a high fever. The patient didn't have EVD — it turned out to be malaria — but the early identification triggered the right isolation procedures immediately. That is exactly how the system is supposed to work.
Australian guidelines require that a history of travel to an endemic or epidemic area within 21 days of illness onset is a key factor in assessing EVD risk.
Isolation Procedures
Once a patient is flagged as a potential EVD case — a "patient under investigation" (PUI) in clinical language — isolation is immediate.
The healthcare worker should record the patient's history while maintaining a distance of at least one metre, even with patients who do not yet show symptoms such as vomiting, diarrhoea, or haemorrhage. Access to the room is restricted. Only essential personnel enter, and only with appropriate PPE.
The response timeline matters. Australian public health units are required to respond to patients under investigation, suspected cases, and confirmed cases immediately — and to enter cases onto the national notifications system within one working day.
Environmental Cleaning and Waste Management
Surfaces and equipment in contact with an EVD patient's bodily fluids require careful decontamination. Standard hospital-grade disinfectants effective against enveloped viruses are appropriate, applied by workers wearing full PPE.
Waste from a patient under investigation must be treated as high-risk biological waste and disposed of in accordance with both state environmental protection regulations and workplace WHS policies. This is an area where many general workplaces — not just hospitals — need documented procedures, because an EVD case can present at any setting before formal diagnosis.
Donning and Doffing — Where Most Risks Occur
Healthcare workers and researchers studying EVD infection control have consistently identified the removal of PPE — "doffing" — as the moment of highest self-contamination risk. A contaminated glove making contact with an unprotected face, a face shield pulled off carelessly — these are the moments where exposure can occur despite perfect donning.
PPE must be removed slowly and deliberately in the correct sequence to reduce the possibility of self-contamination or other viral exposure. Healthcare workers preparing to remove PPE should have a trained observer visually inspect their PPE and use approved disinfectant wipes to remove visible soiling before beginning the doffing process.
This process cannot be learned from a fact sheet alone. It requires hands-on training and regular practice — ideally in a simulated environment before it is ever needed in a real scenario.
Training: The Non-Negotiable Foundation
No PPE protocol, no infection control policy, no emergency procedure works without trained people to implement it. This is where many workplaces fall short — not through bad intentions, but through the assumption that a written procedure is the same as a trained workforce.
Safeguarding the health and wellbeing of healthcare workers includes providing training in hand hygiene, appropriate use of PPE, and safe use and disposal of sharps. This is a priority and responsibility of policy makers, employers, managers, and healthcare workers themselves.
For Australian healthcare workers, infection prevention and control training is directly connected to broader compliance training obligations under the Work Health and Safety Act. The Australian Compliance Institute offers CPD-accredited courses tailored to Australian legislative requirements, including the Infection Prevention & Control (IPC) – NSQHS course, which covers the National Safety and Quality Health Service standards that underpin infection control in Australian healthcare facilities.
For workplaces outside clinical settings, the Workplace Health and Safety course provides the foundational framework for understanding biological hazard obligations under Australian WHS legislation — including how to develop and implement a biological risk management plan.
The WHO's updated IPC guideline for Ebola and Marburg disease, published in 2023, provides the global gold standard on which much of the Australian guidance is based. It is worth consulting alongside Australian-specific resources.
Responsibilities by Workplace Type
Healthcare Settings
Hospitals, clinics, and aged care facilities have the most direct exposure risk and therefore the most specific obligations. Designated isolation capacity, trained IPC teams, stockpiled PPE, documented donning and doffing protocols, and regular simulation drills are all expected standards — not exceptional measures.
Non-Clinical Workplaces
For offices, schools, construction sites, and retail environments, the risk of encountering an active EVD case is extremely low. However, general biological hazard awareness, travel risk policies, and a clear procedure for escalating a concern to a health authority are still reasonable and proportionate inclusions in a WHS plan.
Airports and Border Settings
Australian Border Force personnel and airport healthcare staff operate in an environment where a returning traveller with EVD symptoms is a genuine possibility — however remote. These settings require specific training in recognition, isolation, and escalation procedures, aligned with guidance from the Australian Government Department of Health and Aged Care.
What to Do If You Suspect EVD in Your Workplace
If a person presents in your workplace with symptoms consistent with EVD — fever, severe headache, muscle pain, vomiting, diarrhoea, or unexplained bleeding — and reports recent travel to an endemic area within the past 21 days, the immediate steps are clear.
Do not attempt to manage the situation independently. Contact your state or territory health authority immediately. In most states, this means calling your local Public Health Unit. The CDNA national guidelines provide the overarching framework that public health units will follow.
Limit the movement of the person concerned. Minimise the number of staff who come into contact with them. Document who was present. And follow the advice of public health authorities from that point forward — they are trained exactly for this scenario.
